All roads lead to IL-6: A central hub of cardiometabolic signaling
Authors:
- 1 May 2018
- journal article
- editorial
- Published by Elsevier in International Journal of Cardiology
- Vol. 259, 213-215
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysisEuropean Heart Journal, 2013
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysisThe Lancet, 2012
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studiesThe Lancet, 2012
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6International Journal of Biological Sciences, 2012
- Therapeutic strategies for the clinical blockade of IL-6/gp130 signalingJournal of Clinical Investigation, 2011
- Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)Atherosclerosis, 2009
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000
- Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.Journal of Clinical Investigation, 1990
- Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1Cellular Immunology, 1989